Effect of Regional Anesthesia or Intravenous Infusion of Lidocaine on Morphine Use After Scoliosis Repair Surgery

Launched by ASSAF-HAROFEH MEDICAL CENTER · Jun 4, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how two different pain management techniques can help reduce the amount of morphine needed after scoliosis surgery. The researchers want to find out if using a medication called lidocaine, which helps relieve pain and reduce inflammation, or a method called regional anesthesia can lead to less pain and fewer side effects compared to traditional morphine use. The goal is to improve recovery for patients who experience severe pain after their surgery.

To participate in this study, patients need to be over 12 years old, able to understand and use a special device for pain control after surgery, and have their parent or guardian sign a consent form if they are minors. Those who might be excluded include individuals with a history of chronic pain treatment, certain medical conditions affecting their health, or those who cannot operate the pain control device independently. Participants in the trial can expect to be closely monitored for their pain levels and any side effects they may experience during the first 48 hours after their surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients over the age of 12 with normal cognition, who are scheduled to undergo surgery to correct scoliosis and treatment with IV PCA independently for pain relief after surgery; The patients' parents/guardian (in the case of a minor) or the patient himself (in the case of an adult) signed an informed consent form for participation in the study; Patients should be able to operate the PCA device independently
• Exclusion Criteria:
• • Patients who do not agree to participate in the study even if their parents signed an informed consent
• • Patients who are unable to operate the PCA device independently
• • Patients under treatment with opioids or cannabis for chronic pain for more than a month;
• • Drug use of any kind;
• • Alcoholism;
• • Patients with depression, anxiety or post-trauma;
• • Moderate-severe insufficiency of one of the systems - respiratory/cardiac/hepatic/renal;
• • Sensitivity to one of the drugs in the research protocol.